Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Crescent Capital BDC ( (CCAP) ) just unveiled an update.
On October 30, 2025, Crescent Capital BDC, Inc. entered into a Fourth Supplement to Note Purchase Agreement with institutional investors for the issuance of $185 million in senior unsecured notes, due between 2029 and 2031. The proceeds from these notes are intended for repaying existing indebtedness and general corporate purposes, potentially impacting the company’s financial flexibility and investment capabilities.
The most recent analyst rating on (CCAP) stock is a Hold with a $15.50 price target. To see the full list of analyst forecasts on Crescent Capital BDC stock, see the CCAP Stock Forecast page.
Spark’s Take on CCAP Stock
According to Spark, TipRanks’ AI Analyst, CCAP is a Neutral.
Crescent Capital BDC’s overall stock score is driven by its solid financial performance and attractive valuation, with a high dividend yield. However, technical indicators suggest potential bearish momentum, and the earnings call presented a balanced view with both strengths and challenges. The absence of notable corporate events further consolidates the score.
To see Spark’s full report on CCAP stock, click here.
More about Crescent Capital BDC
Crescent Capital BDC, Inc. operates in the financial services industry, focusing on business development. The company primarily provides investment and financing solutions to middle-market companies, aiming to support their growth and development.
Average Trading Volume: 216,039
Technical Sentiment Signal: Sell
Current Market Cap: $523.3M
Find detailed analytics on CCAP stock on TipRanks’ Stock Analysis page.